Evaluation of [18F]Fluorothymidine as a Biomarker for Early Therapy Response in a Mouse Model of Colorectal Cancer.
Sara RapicChristel VangestelJeroen VerhaegheDavid ThomaePatrick PauwelsTim Van den WyngaertSteven StaelensSigrid StroobantsPublished in: Molecular imaging and biology (2017)
[18F]FLT positron emission tomography was found to be a suitable biomarker of early tumor response to anti-proliferative treatment, with static imaging not being inferior to full compartmental analysis in our xenograft model. The dynamics of thymidine kinase 1 protein expression and protein activity in low ATP environments merits further investigation.